PMVP (PMV Pharmaceuticals) Earnings growth in current year

Official company branding of pmvpharma.com (PMVP)

The diversified synthesis of components ensures research stability and high returns for PMV Pharmaceuticals (PMVP). The volatility of annual earnings per share visualizes this trend, where the 10.80 level represents the current value. The greening of production through closed-loop water systems complements the strategy, while effective stock options retain leading oncobiologists and regulatory experts, strengthening the company's human capital.

PMVP (PMV Pharmaceuticals, Inc.) Earnings growth in current year history from 07/04/2022 to 11/15/2026

Comprehensive metric breakdowns and analytics for PMV Pharmaceuticals (PMVP)

- share price and expert price forecast:
Fundamental valuation:PMVP PMV Pharma
Signature product of PMV Pharmaceuticals, Inc

Investors assess fundamental risks through earnings per share (EPS) dynamics. For PMV Pharmaceuticals (PMVP), which focuses on the clinical development of targeted cancer drugs, profit is primarily driven by investments. The final annual EPS growth rate of 10.80 reflects the percentage change in net income compared to the previous year. This metric measures capital efficiency and market consensus, while sharp spikes in this indicator signal asset volatility.

Direct competitors

GMAB: Net earnings per one share growth for the current year|EXEL (Exelixis Inc.) - Earnings growth in current year|Earnings growth in current year nuvalent.com|Earnings per share growth in current year Kymera (KYMR)|IDYA (IDEAYA Biosciences, Inc.) - Earnings per share increase in current year|Earnings growth in current year ELVN (Enliven Therapeutics Inc)|Net earnings per share change in current year ORIC Pharma|Relay Therapeutics Inc - Earnings growth in current year|Earnings per share growth rate in current year Nurix Therapeutics, Inc.|TYRA (Tyra Biosciences, Inc.) - Net earnings per share growth this year|VSTM: Net earnings per one share growth for the current year|GLUE (monterosatx.com) - Earnings growth in current year|Earnings per share growth rate in current year Cullinan Therapeutics Inc CGEM|Earnings growth in current year IMRX|C4 Therapeutics - Earnings per share growth this year|Black Diamond Therapeutics - Net earnings per share growth this year|Earnings per share increase in current year RPTX|KPTI: Net earnings per share growth this year|propanc.com - Net earnings per one share growth for the current year|BGMS: Earnings growth in current year|Aadi Bioscience Inc - Earnings per share increase in current year|ALRN (Aileron Therapeutics Inc) - Earnings growth in current year|Earnings per share growth rate in current year blueprintmedicines.com BPMC|Earnings per share growth in current year GlycoMimetics Inc. (GLYC)|SWTX (SpringWorks) - Earnings per share increase in current year